Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Paganelli

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2007
Lymphoscintigraphy and sentinel node biopsy in breast cancer: where are we after 10 years?Giovanni Paganelli
Ecancermedicalscience|July 11, 2017
Development of sentinel node biopsy, ROLL and IART in early breast cancer at the European Institute of Oncology, Milan (IEO)Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2003
Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?Giovanni Paganelli, Marco Chinol
European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2011
PET imaging of HER-2-positive tumoursLaura Gilardi, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2010
Is a SUV cut-off necessary in the evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?Laura Gilardi, Giovanni Paganelli
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 9, 2020
Importance of PET with <sup>68</sup>Ga-Labeled Somatostatin AnalogsGiovanni Paganelli, Federica Matteucci
The Lancet. Oncology|May 13, 2018
[<sup>177</sup>Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet?Giovanni Paganelli, Ugo De Giorgi
European Journal of Nuclear Medicine and Molecular Imaging|July 20, 2004
Antibody-based cancer therapies: back to "polyclonals"?Giovanni Paganelli, Rita De Santis
Cancer Biotherapy & Radiopharmaceuticals|January 6, 2011
Something more than estimating renal dosimetryLisa Bodei, Marta Cremonesi, Giovanni Paganelli
Breast Cancer Research and Treatment|April 25, 2013
Improper use of "radioguided occult lesion localization" (ROLL) technique leads to misleading conclusionsGiovanni Paganelli, Laura Gilardi, Umberto Veronesi
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Nuclear Medicine and Molecular Imaging|October 19, 2007
Lymphoscintigraphy and sentinel node biopsy in breast cancer: where are we after 10 years?Giovanni Paganelli
Ecancermedicalscience|July 11, 2017
Development of sentinel node biopsy, ROLL and IART in early breast cancer at the European Institute of Oncology, Milan (IEO)Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|January 31, 2003
Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?Giovanni Paganelli, Marco Chinol
European Journal of Nuclear Medicine and Molecular Imaging|September 20, 2011
PET imaging of HER-2-positive tumoursLaura Gilardi, Giovanni Paganelli
European Journal of Nuclear Medicine and Molecular Imaging|September 8, 2010
Is a SUV cut-off necessary in the evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?Laura Gilardi, Giovanni Paganelli
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 9, 2020
Importance of PET with <sup>68</sup>Ga-Labeled Somatostatin AnalogsGiovanni Paganelli, Federica Matteucci
The Lancet. Oncology|May 13, 2018
[<sup>177</sup>Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet?Giovanni Paganelli, Ugo De Giorgi
European Journal of Nuclear Medicine and Molecular Imaging|July 20, 2004
Antibody-based cancer therapies: back to "polyclonals"?Giovanni Paganelli, Rita De Santis
Cancer Biotherapy & Radiopharmaceuticals|January 6, 2011
Something more than estimating renal dosimetryLisa Bodei, Marta Cremonesi, Giovanni Paganelli
Breast Cancer Research and Treatment|April 25, 2013
Improper use of "radioguided occult lesion localization" (ROLL) technique leads to misleading conclusionsGiovanni Paganelli, Laura Gilardi, Umberto Veronesi
Pageof 22